Skip to main content
OpenTrials

Clinical trial condition

Sarcoma, Ewing

Explore clinical trials studying Sarcoma, Ewing. Study availability and eligibility vary by location and protocol.

192 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma, Ewing trial results

Completed

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 127 locations
View Trial Details
Completed

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

NCT03213665

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details
Completed

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

NCT03526250

Conditions
Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +81 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details
Completed

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

NCT02945800

Conditions
Disease Attributes, Ewing Sarcoma, Myosarcoma, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • A.I. duPont Hospital for Children, Delaware - Nemours Wilmington, Delaware, United States
View all 14 locations
View Trial Details
Completed

A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma

NCT05046314

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

NCT04238819

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) Los Angeles, California, United States
  • Kaiser Permanente Oakland Oakland, California, United States
  • Kaiser Permanente Roseville Roseville, California, United States
View all 25 locations
View Trial Details

Related conditions